Effect of total glucosides of peony on immunological hepatic fibrosis in rats

World Journal of Gastroenterology

Volumn 11, Issue 14, 2005, Pages 2124-2129

  Wang, Hua ^a   Wei, Wei ^a   Wang, Ni Ping ^a   Wu, Cheng Yi ^a   Yan, Shang Xue ^a   Yue, Li ^a   Zhang, Ling Ling ^a   Xu, Shu Yun ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Oxidative stress; Rat; Total glucosides of peony

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ASPARTATE AMINOTRANSFERASE; COLCHICINE; COLLAGEN; EOSIN; FREUND ADJUVANT; GLUTATHIONE PEROXIDASE; HEMATOXYLIN; HYDROXYPROLINE; LAMININ; MALONALDEHYDE; NITRIC OXIDE; PAEONIA EXTRACT; PROCOLLAGEN; SUPEROXIDE DISMUTASE; COLLAGEN TYPE 3; GLUCOSIDE; HERBACEOUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DRUG MECHANISM; LIVER FIBROSIS; LIVER HISTOLOGY; LIVER HOMOGENATE; LIVER STRUCTURE; MALE; MICROSCOPY; NONHUMAN; OXIDATIVE STRESS; RADIOIMMUNOASSAY; RANDOMIZATION; RAT; RAT STRAIN; TISSUE SECTION; ANIMAL; BLOOD; DRUG EFFECT; IMMUNOLOGY; LIVER; LIVER CIRRHOSIS; METABOLISM; PAEONIA; PATHOLOGY;

ANIMALS; COLLAGEN TYPE III; DRUGS, CHINESE HERBAL; GLUCOSIDES; GLUTATHIONE PEROXIDASE; HYDROXYPROLINE; LAMININ; LIVER; LIVER CIRRHOSIS; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; PAEONIA; RATS; SUPEROXIDE DISMUTASE;

EID: 17444404621     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v11.i14.2124     Document Type: Article

References (34)

1. Dai WJ, Jiang HC. Advances in gene therapy of liver cirrhosis: A review. World J Gastroenterol 2001; 7: 1-8
2. Friedman SL. seminars in medicine of the Beth Isyael Hospital Boston. The cellular basis of hepatic fibrosis: Mechanisms and treatment strategies. N Engl J Med 1993; 328: 1828-1835
3. Friedman SL. Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 2000; 275: 2247-2250
4. Mann DA, Smart DE. Transcriptional regulation of hepatic stellate cell activation. Gut 2002; 50: 891-896
5. Bonis PA, Friedman SL, Kaplan MM. Is liver fibrosis reversible? N Engl J Med 2001; 344: 452-454
6. Albanis E, Friedman SL. Hepatic fibrosis. Pathogenesis and principles of therapy. Clin Liver Dis 2001; 5: 315-334
7. Yang XB, Huang ZM, Wang JH. The drug therapy of liver fibrosis. Shijie Huaren Xiaohua Zazhi 2002; 10: 956-957
8. Dai LM, Chen MZ, Xu SY. Protective effects of total glucocides of paeony on experimental hepatitis. Zhongguo Yaolixue Tongbao 1993; 9: 449-453
9. Wang B, Yao YY, Zhou AW, Ge ZD, Chen MZ, Xu SY. Protective effect of total glucosides of paeony on joint damage in adjuvant arthritis rats. Zhongguo Yaolixue Yu Dulixue Zazhi 1996; 10: 211-214
10. Wang B, Yao YY, Zhou AW, Chen MZ, Xu SY. Study on immunomodulatory effect of total glucosides of paeony and its relationship with nitric oxide in adjuvant arthritis rats. Zhongguo Mianyixue Zazhi 1996; 12: 104-106
11. Zhou LL, Wei W, Shen YX, Xu SY. The effects of TGP on CJ-S131-induced systemic lupus erythematosus-like model in mice. Zhongguo Yaolixue Tongbao 2002; 18: 175-177
12. Xu SY, Shen YX, Xu DJ, Wei W, Liang JS. Effects of total glucosides of paeony and moutan cortex on the function of pineal gland in inflammatory-immune regulation in rats. Zhongguo Yaolixue Yu Dulixue Zazhi 1994; 8: 161-165
13. Wei W, Liang JS, Zhou AW, Chen MZ, Xu SY. Effects of total glucosides of paeony on interleukin 2 production. Zhongguo Yaolixue Tongbao 1989; 5: 176-179
14. Ge ZD, Wei W, Shen YX, Wang B, Ding CH, Zhou AW, Zhang AP, Xu SY. Effects of paeoniflorin, total glucosides of paeony removed paeoniflorin on interleukin 2 production by splenic lymphocytes form adjuvant arthritic rats. Anhui Yike Daxue Xuebao 1996; 31: 4-6
15. Gao BB, Dai LM, Xu SY. The scavenging activities of TGM and TGP on free radicals. Suifang Yixueyuan Xuebao 1996; 18: 43-46
16. Wang B, Chen MZ, Xu SY. Regulatory mechanism of total glucosides of paeony on tumor necrosis factor production by peritoneal macrophages in rats. Zhongguo Yaolixue Tongbao 1997; 13: 255-257
17. Wang BE, Wang ZF, Yin WY, Huang SF, Li JJ. Study on experimental immunity model of hepatic fibrosis. Zhonghua Yixue Zazhi 1998; 69: 503-505
18. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-1520
19. Chevallier M, Guerret S, Chossegros P, Gerard F, Grlmaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: Comparison with morphometric studies. Hepatology 1994; 20: 349-355
20. Kiechle FL, Malinski T. Nitric oxide. Biochemistry, pathophysiology, and detection. Am J Clin Pathol 1993; 100: 567-575
21. Gavino VC, Miller JS, Ikharebha SO, Milo GE, Cornwell DG. Effect of polyunsaturated fatty acids and antioxidants on lipid peroxidation in tissue cultures. J Lipid Res 1981; 22: 763-769
22. Jamall IS, Finelli VN, Que Hee SS. A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues. and Biochem 1981; 112: 70-75
23. Fort J, Pilette C, Veal N, Oberti F, Gallois Y, Douay O, Rosenbaum J, Cales P. Effects of long-term administration of interferon alpha in two models of liver fibrosis in rats. J Hepatol 1998; 29: 263-270
24. Friedman SL. Liver fibrosis-from bench to bedside. J Hepatol 2003; 38(Suppl 1): S38-S53
25. Shimizu I, Ma YR, Mizobuchi Y, Liu F, Miura T, Nakai Y, Yasuda M, Shiba M, Horie T, Amagaya S, Kawada N, Hori H, Ito S. Effects of Sho-saiko-to, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 1999; 29: 149-160
26. Li BS, Wang J, Zhen YJ, Liu JX, Wei MX, Sun SQ, Wang SQ. Experimental study on serum fibrosis markers and liver tissue pathology and hepatic fibrosis in immuno-damaged rats. Shijie Huaren Xiaohua Zazhi 1999; 7: 1031-1034
27. Apte M. Oxidative stress: does it initiate hepatic stellate cell activation or only 'perpetuate' the process? J Gastroenterol Hepatol 2002; 17: 1045-1048
28. Serviddio G, Pereda J, Pallardo FV, Carretero J, Borras C, Cutrin J, Vendemiale G, Poli G, Vina J, Sastre J. Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress. Hepatology 2004; 39: 711-720
29. Muriel P, Moreno MG. Effects of silymarin and vitamins E and C on liver damage induced by prolonged biliary obstruction in the rat. Basic Clin Pharmacol Toxicol 2004; 94: 99-104
30. Lu G, Shimizu I, Cui X, Itonaga M, Tamaki K, Fukuno H, Inoue H, Honda H, Ito S. Antioxidant and antiapoptotic activities of idoxifene and estradiol in hepatic fibrosis in rats. Life Sci 2004; 74: 897-907
31. Pietrangelo A. Iron-induced oxidant stress in alcoholic liver fibrogenesis. Alcohol 2003; 30: 121-129
32. Gebhardt R. Oxidative stress, plant-derived antioxidants and liver fibrosis. Planta Med 2002; 68: 289-296
33. Das D, Pemberton PW, Burrows PC, Gordon C, Smith A, McMahon RF, Warnes TW. Antioxidant properties of colchicine in acute carbon tetrachloride induced rat liver injury and its role in the resolution of established cirrhosis. Biochim Biophys Acta 2000; 1502: 351-362
34. Koruk M, Aksoy H, Akcay F, Onuk MD. Antioxidant capacity and nitric oxide in patients with hepatic cirrhosis. Ann Clin Lab Sci 2002; 32: 252-256